UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Chronic inflammation and oxidative stress in human carcinogenesis

International journal of cancer, 2007-12, Vol.121 (11), p.2381-2386

2007

Volltextzugriff (PDF)

Mechanisms of resistance to EGFR-targeted drugs: lung cancer

ESMO open, 2016, Vol.1 (3), p.e000060-e000060, Article e000060

2016

Volltextzugriff (PDF)

Implication of the Hedgehog pathway in hepatocellular carcinoma

World journal of gastroenterology : WJG, 2017-06, Vol.23 (24), p.4330-4340

2017

Volltextzugriff (PDF)

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Nature reviews. Clinical oncology, 2009-09, Vol.6 (9), p.519-527

2009

Volltextzugriff (PDF)

Present and future of metastatic colorectal cancer treatment: A review of new candidate targets

World journal of gastroenterology : WJG, 2017-07, Vol.23 (26), p.4675-4688

2017

Volltextzugriff (PDF)

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

Therapeutic Advances in Medical Oncology, 2021, Vol.13, p.1758835920949418-1758835920949418

2021

Volltextzugriff (PDF)

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (20), p.10100-10111

2006

Volltextzugriff (PDF)

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine

Kidney international, 2019-09, Vol.96 (3), p.555-567

2019

Volltextzugriff (PDF)

Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non–small Cell Lung Cancer Cells to Treatment with Gefitinib

Clinical cancer research, 2007-05, Vol.13 (9), p.2795-2803

2007

Volltextzugriff (PDF)

Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer

Journal of medicinal chemistry, 2017-09, Vol.60 (17), p.7447-7458

2017

Volltextzugriff (PDF)

Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience

Therapeutic advances in medical oncology, 2022, Vol.14, p.17588359221096878

2022

Volltextzugriff (PDF)

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells

Oncotarget, 2016-01, Vol.7 (4), p.4265-4278

2016

Volltextzugriff (PDF)

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

BMC cancer, 2021-05, Vol.21 (1), p.549-549, Article 549

2021

Volltextzugriff (PDF)

The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer

Medical oncology (Northwood, London, England), 2020-06, Vol.37 (6), p.54-54, Article 54

2020

Volltextzugriff (PDF)

How I treat malignant pleural mesothelioma

ESMO open, 2020-03, Vol.4 (Suppl 2), p.e000669-e000669, Article e000669

2020

Volltextzugriff (PDF)

Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype

Medical oncology (Northwood, London, England), 2021-03, Vol.38 (3), p.24-24, Article 24

2021

Volltextzugriff (PDF)

AXL is an oncotarget in human colorectal cancer

Oncotarget, 2015-09, Vol.6 (27), p.23281-23296

2015

Volltextzugriff (PDF)

Discovery of N-Substituted-2-Oxoindolin Benzoylhydrazines as c-MET/SMO Modulators in EGFRi-Resistant Non-Small Cell Lung Cancer

RSC medicinal chemistry, 2024-10

2024

Volltextzugriff (PDF)

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program

Tumor biology, 2018-11, Vol.40 (11), p.1010428318815047-1010428318815047

2018

Volltextzugriff (PDF)

Early use of steroids affects immune cells and impairs immunotherapy efficacy

ESMO open, 2019-01, Vol.4 (1), p.e000477-e000477, Article e000477

2019

Volltextzugriff (PDF)

Analysis of DNA from liquid biopsy: new genetic biomarkers for cancer immunotherapy?

Exploration of targeted anti-tumor therapy, 2021-01, Vol.2 (2), p.204-207

2021

Volltextzugriff (PDF)

Resistance to epidermal growth factor receptor-targeted therapy

Drug resistance updates, 2005-10, Vol.8 (5), p.298-310

2005

Volltextzugriff (PDF)

Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up

Gastrointestinal disorders (Basel, Switzerland), 2023-09, Vol.5 (3), p.367-375

2023

Volltextzugriff (PDF)

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

ESMO open, 2020-01, Vol.5 (5), p.e000753-e000753, Article e000753

2020

Volltextzugriff (PDF)

1 – 25 von 146

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(146)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(105)
Science & Technology
(105)
Oncology
(77)
Humans
(67)
Female
(30)
Animals
(26)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(24)
Lung Neoplasms - Drug Therapy
(24)
Lung Cancer
(20)
Cancer
(19)
Male
(18)
Respiratory System
(18)
Cell Line, Tumor
(17)
Lung Neoplasms - Pathology
(17)
Mice
(16)
Nsclc
(16)
Carcinoma, Non-Small-Cell Lung - Pathology
(15)
Immunotherapy
(15)
Tumors
(15)
Biological And Medical Sciences
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Esmo Open
(10)
Journal Of Thoracic Oncology
(10)
Clinical Cancer Research
(9)
Oncotarget
(9)
Lung Cancer
(7)
Journal Of Clinical Oncology
(5)
Cancer Research
(4)
Cancers
(4)
Clinical Lung Cancer
(4)
Expert Opinion On Investigational Drugs
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Chronic inflammation and oxidative stress in human carcinogenesis

Mechanisms of resistance to EGFR-targeted drugs: lung cancer

Implication of the Hedgehog pathway in hepatocellular carcinoma

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Present and future of metastatic colorectal cancer treatment: A review of new candidate targets

Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy

EPHA2 Is a Predictive Biomarker of Resistance and a Potential Therapeutic Target for Improving Antiepidermal Growth Factor Receptor Therapy in Colorectal Cancer

Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib

Summary of the International Conference on Onco-Nephrology: an emerging field in medicine

Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non–small Cell Lung Cancer Cells to Treatment with Gefitinib

Dual MET and SMO Negative Modulators Overcome Resistance to EGFR Inhibitors in Human Nonsmall Cell Lung Cancer

Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience

Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials

The texture analysis as a predictive method in the assessment of the cytological specimen of CT-guided FNAC of the lung cancer

How I treat malignant pleural mesothelioma

Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype

AXL is an oncotarget in human colorectal cancer

Discovery of N-Substituted-2-Oxoindolin Benzoylhydrazines as c-MET/SMO Modulators in EGFRi-Resistant Non-Small Cell Lung Cancer

Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program

Early use of steroids affects immune cells and impairs immunotherapy efficacy

Analysis of DNA from liquid biopsy: new genetic biomarkers for cancer immunotherapy?

Resistance to epidermal growth factor receptor-targeted therapy

Vedolizumab as Rescue Therapy in Carboplatin-Gemcitabine-Induced Triggered Acute Severe Ulcerative Colitis Flare-Up

Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer

Aktive Filter

Suchergebnisse filtern